Last reviewed · How we verify
NCT05242198
Rectus Sheath Block May Relieve Urethral Catheter Pain
NA trial testing Robotic prostatectomy in Prostatectomy in 60 participants. Completed in 21 September 2022.
30 August 2022
Quick facts
| Lead sponsor | V.K.V. American Hospital, Istanbul |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 15 March 2022 |
| Primary completion | 30 August 2022 |
| Estimated completion | 21 September 2022 |
| Sites | 2 locations across Turkey (Türkiye) |
Drugs / interventions tested
- Robotic prostatectomy
Conditions studied
- Prostatectomy — all drugs for Prostatectomy →
Sponsor
V.K.V. American Hospital, Istanbul
Who can join
Adults 18 to 79, male only, with Prostatectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to investigate the analgesic efficacy of rectus sheath block and its effect on urethral catheter discomfort in robotic prostatectomy operations.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The effect of ultrasound-guided rectus sheath block on postoperative analgesia in robot assisted prostatectomy: A randomized controlled trial.
Coşarcan SK, Gürkan Y, Manici M, Özdemir İ, et al · · 2024 · cited 3× · PMID 38669407 · DOI 10.1097/md.0000000000037975
Verify or expand the search:
- PubMed search for NCT05242198
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prostatectomy
Currently open trials in the same condition.
- NCT06274047 — PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life i · Phase 3 · recruiting
- NCT06982469 — High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy · recruiting
- NCT03080116 — Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy · Phase 2 · active not recruiting
Other V.K.V. American Hospital, Istanbul trials
Trials by the same sponsor.
- NCT06705595 — The Effect of Local Anesthetic Techniques on Hemodynamic Response and Postoperative Sore Throat in Double-Lumen Tubes · NA · completed
- NCT06707818 — Psychosocial Factors and Postoperative Pain in Aesthetic Breast Surgery · completed
- NCT06138119 — The Impact of Gender Stereotypes on Fiberoptic Intubation Performance · NA · completed
- NCT05241977 — MINIMUM EFFECTIVE VOLUME OF BUPIVACAİNE FOR ANTERIOR SUPRASCAPULAR NERVE BLOCK · completed
- NCT05282303 — REGIONAL ANALGESIA TECHNIQUES FOR EFFECTIVE RECOVERY TO CORONARY ARTERY BYPASS SURGERIES: A RETROSPECTİVE STUDY IN A SIN · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05242198 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by V.K.V. American Hospital, Istanbul
- Last refreshed: 20 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05242198.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing